Recent Insider Buying: Alcoa Inc. (NYSE:AA), Citigroup Inc. (NYSE:C), Molycorp Inc. (NYSE:MCP), Eli Lilly and (NYSE:LLY)

Alcoa Inc. (NYSE:AA) Director Ratan Tata purchased 1,670 shares of the company’s stock in a transaction that occurred on Friday, April 11th. The shares were purchased at an average price of $12.48 per share, for a total transaction of $20,841.60. Alcoa Inc. (NYSE:AA) shares after opening at $13.49 moved to $13.61 on last trade day and at the end of the day closed at $13.51. Company price to sales ratio in past twelve months was calculated as 0.70 and price to cash ratio as 23.79. Alcoa Inc. (NYSE:AA) showed a positive weekly performance of 5.05%.

Citigroup (NYSE:C) CEO Barbara Desoer bought 1,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. The shares were purchased at an average price of $48.19 per share, for a total transaction of $48,190.00. Following the completion of the transaction, the chief executive officer now directly owns 1,000 shares in the company, valued at approximately $48,190. Citigroup Inc. (NYSE:C) shares advanced 0.38% in last trading session and ended the day on $48.02. C return on equity ratio is recorded as 8.50% and its return on assets is 0.90%. Citigroup Inc. (NYSE:C) yearly performance is 6.45%.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Bruce Kovner bought 1,250,000 shares of Synta Pharmaceuticals Corp. stock on the open market in a transaction dated Friday, April 11th. The shares were purchased at an average price of $4.01 per share, for a total transaction of $5,012,500.00. Following the acquisition, the director now directly owns 3,048,666 shares in the company, valued at approximately $12,225,151. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) shares moved up 9.48% in last trading session and was closed at $4.39, while trading in range of $4.10 – $4.39. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) year to date (YTD) performance is -16.22%.

Eli Lilly and Co (NYSE:LLY) Director Ralph Alvarez purchased 146 shares of the company’s stock in a transaction that occurred on 31 March. The shares were purchased at an average price of $58.17 per share, for a total transaction of $8,595. Eli Lilly and Co (NYSE:LLY) weekly performance is 1.83%. On last trading day company shares ended up $60.03. Eli Lilly and Co (NYSE:LLY) distance from 50-day simple moving average (SMA50) is 3.35%. Analysts mean target price for the company is $59.82.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *